Praised by his PhD students for his compassion, enthusiasm, and collaborative nature, University of Colorado Cancer Center member Edward Chuong, PhD, is one of 13 faculty members at CU Boulder to be recognized as an outstanding graduate student mentor for 2024 ..read more

Asked if there’s a lesson for other medical researchers in his decades-long career, York Miller, MD, says it’s this: “If you see something promising, don’t be reluctant to change direction ..read more

After a well-documented breast cancer journey that lasted nearly a decade, actress Shannen Doherty — best known for her role as Brenda Walsh on the Fox teen drama “Beverly Hills, 90210” — died from the cancer on July 13, at age 53. Her publicist shared the news ..read more

Ovarian cancer is one of the leading causes of cancer death among women, with nearly 20,000 new diagnoses each year and around 12,740 deaths from the disease estimated in 2024, according to the American Cancer Society ..read more

University of Colorado Cancer Center member Dr. Steven Thorpe emphasizes the collaborative nature of treating soft tissue and bone sarcomas, highlighting the multidisciplinary efforts at CU School of Medicine's Department of Orthopedics and Children’s Hospital Colorado. He underscores the goal of not only curing the disease but also preserving function through advanced surgical techniques and modern therapies, ensuring patients maintain quality of life post-treatment. Thorpe stresses the importance of long-term outcomes, tailoring treatments to support patients’ aspirations beyond their cancer ..read more

A new program launched by the University of Colorado Cancer Center, in partnership with the Center for Health, Work, and Environment at the Colorado School of Public Health (ColoradoSPH), aims to provide comprehensive support to cancer patients as they balance work responsibilities and treatment ..read more

Multidisciplinary care, access to clinical trials, and genetic and molecular testing all are hallmarks of sarcoma treatment at the University of Colorado Cancer Center, which averages nearly 300 new sarcoma patients each year ..read more

CU Cancer Center member S. Lindsey Davis, MD, highlighted that the combination therapy of sapanisertib and alisertib showed marginal clinical benefit for patients with advanced solid tumors, correlative analyses suggested that apoptotic response and tumor immune cell infiltrate might influence clinical outcomes. The phase 1b study's expansion cohort indicated some positive outlying responses among patients and underscore the need for further research to tailor treatments for standout patients and explore rational combinations to enhance efficacy ..read more

Sapna Patel, MD, a widely renowned melanoma oncologist and clinical investigator, has joined the University of Colorado Cancer Center and the CU Department of Medicine, with a goal of helping to build a “pinnacle of skin cancer treatment” in the Rocky Mountains ..read more

Sean Davis, MD, PhD, associate director of informatics and data science at the University of Colorado Cancer Center, is part of a team that recently received a $5.2 million grant renewal from the National Institutes of Health (NIH) to continue funding cancer genomics research.  ..read more